Oravax's oral VLP vaccine in development targets three SARS CoV-2 virus surface proteins, including proteins less susceptible to mutation, thus making the vaccine potentially more effective against current and future variants of the Covid-19 virus
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
The QuickVue antigen tests are able to detect the live Omicron variant with similar performance as with other variants
The glucometer connects to one’s smartphone and provides actionable diagnostic information
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
It will be marketed under the brand name Molunamax
G42 Healthcare and AstraZeneca will work closely together to explore real-world evidence and conduct clinical trials through IROS – the first-of-its-kind Contract Research Organization (CRO) in the UAE
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
DCGI approved the drug based on the review of clinical data
The company has developed the API in house at its R&D center in Hyderabad
Subscribe To Our Newsletter & Stay Updated
